SecSonar.com

IDEXX Laboratories, Inc. (IDXX)

IDEXX Laboratories, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

IDEXX Laboratories, Inc. (IDXX) is a Medical - Diagnostics & Research company based in US with a market capitalization of $44.5B. Revenue grew 10.4% year-over-year and the company generated $1.1B in free cash flow. This page tracks IDXX's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 11K employees · IPO Jun 21, 1991

Valuation

Valuation & price

$528.79 · as of May 17, 2026 · -31.0% vs 52w high

40.3

P/E ratio

Latest-FY diluted EPS

27.72

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$767$643$519Jul 25Dec 25Jul 26Jul 7, 25$545.56Jul 9, 25$540.64Jul 11, 25$533.37Jul 15, 25$526.66Jul 17, 25$518.71Jul 21, 25$520.87Jul 23, 25$540.68Jul 25, 25$565.19Jul 29, 25$573.07Jul 31, 25$534.31Aug 4, 25$682.78Aug 6, 25$624.19Aug 11, 25$652.11Aug 13, 25$663.92Aug 15, 25$650.84Aug 19, 25$636.71Aug 21, 25$633.05Aug 25, 25$641.35Aug 27, 25$640.86Aug 29, 25$647.09Sep 3, 25$633.95Sep 5, 25$642.99Sep 9, 25$655.60Sep 11, 25$645.16Sep 16, 25$645.65Sep 18, 25$655.51Sep 22, 25$644.10Sep 24, 25$627.17Sep 26, 25$632.22Sep 30, 25$638.89Oct 2, 25$633.84Oct 6, 25$627.78Oct 8, 25$629.91Oct 10, 25$616.15Oct 14, 25$636.91Oct 16, 25$637.34Oct 21, 25$637.13Oct 23, 25$638.60Oct 27, 25$647.40Oct 29, 25$627.66Oct 31, 25$629.51Nov 4, 25$722.12Nov 6, 25$713.74Nov 10, 25$709.59Nov 12, 25$713.56Nov 14, 25$689.93Nov 18, 25$670.21Nov 20, 25$689.35Nov 25, 25$766.68Nov 28, 25$752.88Dec 2, 25$732.73Dec 4, 25$717.47Dec 8, 25$706.65Dec 10, 25$701.83Dec 12, 25$704.20Dec 16, 25$693.18Dec 18, 25$697.10Dec 22, 25$702.12Dec 24, 25$688.18Dec 29, 25$687.89Jan 2, 26$669.99Jan 6, 26$706.83Jan 8, 26$712.39Jan 12, 26$724.76Jan 14, 26$710.48Jan 16, 26$715.37Jan 21, 26$696.46Jan 23, 26$693.85Jan 27, 26$694.75Jan 29, 26$676.71Feb 2, 26$639.60Feb 4, 26$642.94Feb 9, 26$639.79Feb 11, 26$648.73Feb 13, 26$629.35Feb 18, 26$634.90Feb 20, 26$635.66Feb 24, 26$649.23Feb 26, 26$660.71Mar 2, 26$636.70Mar 4, 26$648.70Mar 6, 26$608.41Mar 10, 26$598.85Mar 12, 26$571.21Mar 17, 26$586.98Mar 19, 26$579.85Mar 23, 26$578.51Mar 25, 26$575.72Mar 27, 26$558.32Mar 31, 26$561.89Apr 2, 26$569.55Apr 7, 26$574.80Apr 9, 26$584.75Apr 13, 26$574.00Apr 15, 26$580.76Apr 17, 26$589.25Apr 22, 26$578.35Apr 24, 26$565.93Apr 28, 26$568.30Apr 30, 26$560.80May 4, 26$563.12May 6, 26$579.23May 8, 26$560.11May 12, 26$533.92May 14, 26$532.86May 18, 26$545.79May 20, 26$553.58May 22, 26$559.37May 28, 26$568.03Jun 1, 26$566.79Jun 3, 26$560.73Jun 5, 26$562.16Jun 9, 26$578.89Jun 11, 26$557.91Jun 15, 26$570.00Jun 17, 26$546.09Jun 22, 26$545.73Jun 24, 26$549.16Jun 26, 26$551.50Jul 2, 26$557.80
$514.6152-week range$766.68
Loading valuation history…

Fundamentals

Key fundamentals

$44.5B

Market cap

10.4%

Revenue growth (YoY)

61.8%

Gross margin

$1.1B

Free cash flow (USD)

$897.1M

Net debt

-2.9%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$1.8BFY 2017$2.0BFY 2018$2.2BFY 2019$2.4BFY 2020$2.7BFY 2021$3.2BFY 2022$3.4BFY 2023$3.7BFY 2024$3.9BFY 2025$4.3B
$1.8B$4.3B

Free cash flow by year

2016 → 2025

FY 2016$269.8MFY 2017$296.6MFY 2018$277.1MFY 2019$303.9MFY 2020$540.4MFY 2021$636.0MFY 2022$394.1MFY 2023$772.9MFY 2024$798.1MFY 2025$1.1B
$269.8M$1.1B

Gross margin by year

2021 → 2025

FY 202158.8%FY 202259.5%FY 202359.8%FY 202461.0%FY 202561.8%
58.8%61.8%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 5, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventBy-Laws AmendedMay 15, 2026Filing
  • 8-K eventEarnings ReleaseMay 5, 2026Filing
  • Quarterly report10-Q FiledMay 5, 2026Filing

Questions

Frequently asked questions

What is IDEXX Laboratories, Inc.'s market cap?

IDEXX Laboratories, Inc. (IDXX) has a market capitalization of $44.5B.

What is IDXX's P/E ratio?

IDXX trades at a price-to-earnings ratio of 40.3, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is IDXX's price-to-book (P/B) ratio?

IDXX trades at 27.72 times book value per share.

Are insiders buying IDXX stock?

SEC Form 4 filings show no open-market insider buys at IDEXX Laboratories, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Medical - Diagnostics & Research

A

Agilent Technologies, Inc.

$38.7B

NTRA

Natera, Inc.

$31.7B

IQV

IQVIA Holdings Inc.

$30.5B

WAT

Waters Corporation

$25B

ILMN

Illumina, Inc.

$25B

MTD

Mettler-Toledo International Inc.

$23.8B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.